+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Budesonide"

From
From
From
Budesonide Inhalation Aerosol Market in Canada - Product Thumbnail Image

Budesonide Inhalation Aerosol Market in Canada

  • Report
  • February 2026
  • 223 Pages
  • Canada
From
Budesonide Inhalation Aerosol Market in China - Product Thumbnail Image

Budesonide Inhalation Aerosol Market in China

  • Report
  • February 2026
  • 232 Pages
  • China
From
Budesonide Inhalation Aerosol Market in India - Product Thumbnail Image

Budesonide Inhalation Aerosol Market in India

  • Report
  • February 2026
  • 225 Pages
  • India
From
COPD in the United States: Understanding the COPD Patient Experience - Product Thumbnail Image

COPD in the United States: Understanding the COPD Patient Experience

  • Report
  • January 2024
  • 156 Pages
  • United States
Research Report on China's Mesalazine Market, 2021-2025 - Product Thumbnail Image

Research Report on China's Mesalazine Market, 2021-2025

  • Report
  • September 2021
  • 40 Pages
  • China
From
Loading Indicator

Budesonide is a corticosteroid used to treat respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and bronchitis. It is available in both inhalation and oral forms, and is used to reduce inflammation in the airways. Budesonide is a synthetic corticosteroid, meaning it is similar to the hormones produced naturally by the body. It works by reducing inflammation in the airways, which helps to reduce symptoms such as wheezing, coughing, and shortness of breath. Budesonide is a widely used drug in the respiratory market, and is often prescribed as a first-line treatment for asthma and COPD. It is generally well-tolerated and has fewer side effects than other corticosteroids. It is also used in combination with other drugs to treat more severe cases of respiratory diseases. Some companies in the Budesonide market include AstraZeneca, GlaxoSmithKline, Merck, and Teva Pharmaceuticals. Show Less Read more